Congenital Measles: The 14-, 6- and 28-Day Clocks That Matter Most
Congenital measles is alarming but narrow: the baby's risk hinges on a mother's rash near delivery, and each protective step has its own deadline. What Pennsylvania doctors were told, and what no one has counted.
About one in three babies born within 14 days of their mother's measles rash will develop congenital measles, according to Pennsylvania's health department. That figure does not describe every pregnancy with measles, and it does not describe vaccinated women. It describes a narrow slice of births, the ones that land close to the mother's rash.
The department put the number in front of clinicians on Monday, Oct. 19, in the department's advisory. Much of the press has called it an alert, but the document labels itself an "Advisory," the middle of the state's three message types, one that "may not require immediate action." Figures here are as of Oct. 19, 2026, unless stated otherwise.
The American Academy of Pediatrics sits a little lower. CIDRAP, summarizing its guidance, reported "an estimated 25% to 30%" of babies whose mothers have measles at birth are also infected. Read the two as roughly 25% to one-third, for births near the rash only.
The risk sits in a 14-day window
Three terms get blurred in headlines, and the advisory keeps them apart. Congenital measles means a newborn with clinical or lab evidence of measles in the first 10 days of life after exposure inside the womb. Neonatal measles is different: the baby is exposed after birth, through the respiratory route. "Perinatal" is the umbrella that covers both.
Then there is the baby who is merely exposed. The advisory says all newborns of women who had measles during pregnancy, whatever the gestational age, "should be considered exposed to measles." That is a reason to watch and test, not a diagnosis.
The two numbers, 10 and 14, are linked. Ten days is the longest reported gap between a mother's rash and her newborn's rash after womb exposure. Add a four-day presumptive infectious period and you get 14. Babies born from the mother's symptom onset through 14 days after her rash are at risk of symptomatic, transmissible measles. A baby born at 34 weeks or later, more than 14 days after the rash, is "considered to not have risk" of that. Infection may have happened in the womb, but the baby would generally not be expected to be infectious at birth.
Measles in pregnancy carries risks of its own. The advisory lists higher maternal odds of hospitalization, pneumonia, oxygen support, ventilation and death. Evidence does not support a link to birth defects, it says, but infection is tied to miscarriage, stillbirth, low birth weight and preterm labor. Dr. Pia Pannaraj put the asymmetry bluntly.
"Mom takes the hit of getting the disease, but the infants are at the highest risk for measles complications of anybody that could get measles."
Dr. Pia Pannaraj, AAP Committee on Infectious Diseases, UC San Diego
What the newborn looks like varies enormously. The advisory describes a range "from asymptomatic, to a mild illness in which the classic measles rash may or may not be present, to a rapidly fatal disease." The rash may be "atypical, delayed, or absent," so a clean-looking baby proves little.
Each protective step has its own clock. Side by side:
| Clock | What it governs | Source in the advisory |
|---|---|---|
| 10 days | A baby with signs of measles in the first 10 days of life after exposure in the womb counts as congenital measles | Definition |
| 14 days | Babies born from the mother's symptom onset through 14 days after her rash are at risk of symptomatic, contagious measles | Newborn guidance |
| 6 days | Window for immune globulin after exposure in a pregnant woman who is not immune | Post-exposure |
| 28 days | Wait after an MMR shot before pregnancy; also quarantine length after immune globulin | Prevention / exposure |
| 72 hours | MMR as post-exposure protection for non-pregnant or postpartum women | Post-exposure |
What the state has not counted
Here the numbers thin out. Pennsylvania has not published a count of congenital cases. The most-cited figure, that at least six babies in the state have been born infected, two of them sick enough for intensive care, came from a Pennsylvania doctor and was reported by NBC News on Sept. 24. It was not a state tally, and 26 days later there is still none.
Pregnancy figures are also stale. As of Friday, Oct. 2, the state told The 19th that 53 of Pennsylvania's 977 reported cases were among pregnant women. That is 5.4%. The state's Oct. 19 release gave no newer pregnancy number.
A report from Ontario clinicians said that as of Aug. 25, 2025, pregnant individuals made up 51 of Ontario's cases (2.2%), "resulting in nine confirmed cases of cM, including one neonatal death." Do not divide nine by 51 and call it a risk; the denominators differ in timing, so these are two facts, not a rate. Before immune globulin, the report adds, mortality "approached 20%–50%."
Immunity is the step that cannot wait for pregnancy
Doctors were told to isolate, identify and inform: mask and isolate suspected or exposed patients, check immunity, exposure and symptoms, and report suspected cases at once to 877-PA-HEALTH (877-724-3258) or the local health department.
For newborns, the guidance is specific. A baby born from the mother's symptom onset through 14 days after her rash should be delivered and managed in airborne isolation until infectiousness can be determined, with swabs and urine tested. In a newborn with no symptoms, a negative test at birth "does not fully rule out congenital measles," so doctors are told to monitor through 14 days after the mother's rash and consider retesting around day 10 of life. Whether mother and baby are separated is "a joint parent-provider decision," and expressed breast milk can be given either way.
Treatment, once infection is present, is limited.
"There's only basically what we call supportive care."
Dr. Pia Pannaraj, AAP Committee on Infectious Diseases, UC San Diego
That is why prevention carries the weight. If you are planning a pregnancy, find your vaccine records; with none, ask about a shot or an antibody test. The test has limits. The advisory says IgG antibody tests "are not 100 percent sensitive and may fail to detect preexisting immunity," and rubella immunity "cannot be used as a proxy" for measles immunity. The CDC says there is "no harm in getting another dose if you may already be immune." MMR is a live vaccine, so pregnancy should wait 28 days after a shot (the CDC says at least a month).
If you are already pregnant and not immune, do not take MMR; the advisory says it should not be given during pregnancy. If you think you were exposed, call your clinician right away. Exposure means shared airspace with an infectious person, or up to two hours after that person leaves; people with measles are infectious from four days before the rash to four days after. Non-immune pregnant women should be offered intravenous immune globulin within six days of the exposure, and ACOG's practice advisory gives the dose as 400 mg/kg. Quarantine runs 21 days from the last exposure, or 28 if you receive it. Preterm labor should be considered a potential sign of measles in an exposed non-immune woman.
Immune globulin is a patch, not a replacement. For babies who already have congenital measles, Dr. Adam J. Ratner told CIDRAP, it "may help make the infection somewhat milder."
After delivery, a mother without immunity should get MMR, ideally before leaving the hospital; ACOG says it is safe while breastfeeding. Vaccinate the people who will care for the baby, too, for the first six months before the baby is eligible. In counties flagged for sustained transmission, the state also recommends an early "zero dose" at 6 through 11 months, which does not replace the two routine doses. Vitamin A does not prevent measles, and pregnant women should not take more than 10,000 IU of preformed vitamin A a day because high intake is linked to birth defects.
For a woman with two documented MMR doses, the advisory is not a reason for alarm. The CDC puts two doses at 97% effective. As of Oct. 19, the statewide update counts 4 cases among vaccinated people out of 1,286, under 1%. (Why those rare cases happen is its own story.) That is no guarantee. It is a very different starting position, and the one that cannot be built after conception. For more on why measles keeps returning, see our earlier explainer.
A rare aftermath with no clean number
The advisory also describes "immune amnesia," a months-to-years weakening of the immune system that raises the risk of other infections, and subacute sclerosing panencephalitis, or SSPE, which "can occur months to years after apparent full recovery." The CDC says congenital measles "is associated with a higher risk of SSPE." Ratner calls SSPE "essentially invariably fatal."
"There have been cases of children who had early-life measles, including congenital measles, who have had a much shorter latency period—more like a couple of years than seven to 10 years—and have gotten SSPE. Now this is still a very small number of kids who we're talking about, because SSPE is very rare."
Dr. Adam J. Ratner, member of the AAP Committee on Infectious Diseases
How rare? The sources reviewed contain no SSPE rate specific to congenital measles. The numbers that exist are for measles in children generally, and they differ widely in method. A German study estimated 1 in 1,700 to 1 in 3,300 for children infected below age 5. It cited a UK estimate of 1 in 5,500 after measles in the first year of life and 1 in 90,000 at 5 and older, and a US study of 1 in 9,100 to 15,400. None is a Pennsylvania number.
On the surveillance side, the state submitted a formal Epi-Aid request to the CDC on Oct. 7. On Oct. 19, 12 days later, one Epidemic Intelligence Service officer joined the department on site, to work on nowcast modeling (real-time projections of case trajectories), incidence and burden modeling, and vaccination impact analysis. The department has about 300 staff, 60 of them its own "disease detectives."
The department has told The 19th it cannot confirm any estimate of congenital cases, and that no national definition exists. A CDC officer is now on site to model how much measles Pennsylvania has. The count of its newborns remains a doctor's estimate of at least six.
